iMetabolic Biopharma Corporation
https://imbiopharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From iMetabolic Biopharma Corporation
Deal Watch: PDS And Edge Merge To Progress HPV-Linked Cancer Immunotherapy
Immunotherapy firms Edge and PDS announce planned merger, while Telix advances its prostate cancer strategy by acquiring ANMI. Kyowa Hakko Kirin is signed up to distribute GlaxoSmithKline's Phase III CKD-associated anemia product daprodustat in Japan.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice